
Tilray Brands, Inc. (NASDAQ:TLRY - Free Report) - Equities researchers at Atb Cap Markets issued their Q4 2026 EPS estimates for shares of Tilray Brands in a note issued to investors on Tuesday, July 29th. Atb Cap Markets analyst F. Gomes forecasts that the company will earn ($0.01) per share for the quarter. The consensus estimate for Tilray Brands' current full-year earnings is ($0.20) per share.
A number of other analysts also recently weighed in on the stock. Piper Sandler reduced their target price on shares of Tilray Brands from $2.00 to $1.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 9th. Roth Capital reissued a "neutral" rating on shares of Tilray Brands in a research report on Monday, April 14th. Wall Street Zen downgraded shares of Tilray Brands to a "strong sell" rating in a research report on Saturday, July 5th. Finally, Zelman & Associates reissued a "neutral" rating on shares of Tilray Brands in a research report on Tuesday, July 29th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $1.92.
Read Our Latest Stock Report on TLRY
Tilray Brands Stock Down 2.1%
Shares of NASDAQ:TLRY traded down $0.01 during midday trading on Thursday, reaching $0.57. The company's stock had a trading volume of 20,437,416 shares, compared to its average volume of 47,214,824. The firm has a 50 day moving average of $0.51 and a 200-day moving average of $0.63. The firm has a market capitalization of $572.40 million, a P/E ratio of -0.25 and a beta of 1.85. The company has a quick ratio of 1.61, a current ratio of 2.46 and a debt-to-equity ratio of 0.20. Tilray Brands has a 12-month low of $0.35 and a 12-month high of $1.98.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last released its earnings results on Monday, July 28th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.05. The firm had revenue of $224.54 million for the quarter, compared to the consensus estimate of $250.41 million. Tilray Brands had a negative net margin of 265.69% and a negative return on equity of 6.83%.
Institutional Trading of Tilray Brands
Institutional investors have recently made changes to their positions in the stock. Lido Advisors LLC bought a new position in shares of Tilray Brands in the 4th quarter worth approximately $28,000. NewEdge Advisors LLC lifted its stake in shares of Tilray Brands by 92.1% in the 4th quarter. NewEdge Advisors LLC now owns 27,406 shares of the company's stock worth $36,000 after purchasing an additional 13,136 shares during the period. Bank of Nova Scotia bought a new position in shares of Tilray Brands in the 4th quarter worth approximately $41,000. Zacks Investment Management bought a new position in shares of Tilray Brands in the 4th quarter worth approximately $41,000. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Tilray Brands by 55.1% in the 4th quarter. Tower Research Capital LLC TRC now owns 31,875 shares of the company's stock worth $42,000 after purchasing an additional 11,325 shares during the period. Hedge funds and other institutional investors own 9.35% of the company's stock.
Insider Activity
In related news, CEO Irwin D. Simon purchased 165,000 shares of the company's stock in a transaction dated Wednesday, July 30th. The shares were purchased at an average price of $0.61 per share, with a total value of $100,650.00. Following the acquisition, the chief executive officer directly owned 3,941,633 shares in the company, valued at $2,404,396.13. The trade was a 4.37% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.60% of the stock is currently owned by insiders.
About Tilray Brands
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading

Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.